Margaret MacMillan, M.D.
Dr. MacMillan received her MSc degree at the University of Toronto in 1989 and her M.D. degree at the University of Toronto in 1991. She completed her internship residency in pediatrics, and postdoctoral fellowship in hematology-oncology at the University of Toronto School of Medicine in 1997. She then completed a blood and marrow transplant fellowship at the University of Minnesota in 1999 after which she joined the faculty, where she is currently an associate professor of pediatrics in the Division of Hematology-Oncology and Blood and Marrow Transplantation and attends on the Pediatric Blood and Marrow Transplantation service. Dr. MacMillan is the clinical medical director and fellowship director of the Pediatric BMT Program.
“My current research focus is on the development and implementation of novel therapeutic strategies for preventing the early toxicities of allogeneic hematopoietic stem cell transplantation. In collaboration with Bruce Blazar, M.D., I am studying the safety and efficacy of T regulatory cells to prevent graft-versus-host disease, a major cause of morbidity and mortality after transplantation. I am also the co-director of the University of Minnesota Fanconi Anemia Comprehensive Care Clinic, which follows the largest number of Fanconi anemia patients in the world. We are currently investigating whether we can successfully transplant Fanconi anemia patients using a reduced radiation dose protocol to help prevent toxicities.”
Committed to finding a cure
“As a young child when someone asked me what I wanted to do when I was older, I always replied, ‘Cure cancer.’ I’m not really sure where this came from as no one in my family had cancer and no one was in medicine. Nevertheless the goal never abated. I feel fortunate to have the ability to help take care of children with cancer. They are in such need for help. I can’t imagine turning my back on them.”
Children's Cancer Research Fund: Making a difference
“The Children’s Cancer Research Fund allows me to give children with cancer hope for a future. Children's Cancer Research Fund provides vital funding to initiate novel research. This leads in turn to preliminary data which then can be used to pursue larger national grants.”